Effects of nCPAP treatment on quality of life of patients with obstructive sleep apnoea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 410s Year: 2006
CPAP treatment for obstructive sleep apnoea syndrome after CPAP training term Source: Eur Respir J 2002; 20: Suppl. 38, 102s Year: 2002
Possibility of treating patients with obstructive sleep apnea syndrome and nocturnal asystoles using CPAP therapy Source: Annual Congress 2009 - Clinical aspects of sleep apnoea Year: 2009
Pitolisant long term effect in sleepy obstructive sleep apnea patients with CPAP Source: Sleep and Breathing Conference 2021 Year: 2021
Pitolisant long term effect in sleepy obstructive sleep apnea patients without CPAP Source: Sleep and Breathing Conference 2021 Year: 2021
CPAP variability in long term follow-up of OSAS (obstructive sleep apnea syndrome) patients Source: Eur Respir J 2006; 28: Suppl. 50, 412s Year: 2006
Pitolisant long term effect in sleepy obstructive sleep apnea patients without CPAP. Source: Virtual Congress 2021 – Advances in therapeutic plans for sleep disordered breathing Year: 2021
Pitolisant long term effect in sleepy obstructive sleep apnea patients with CPAP. Source: Virtual Congress 2021 – Different treatment modalities and impact of comorbidities on sleep disordered breathing Year: 2021
Compliance with CPAP/BiPAP treatment in obstructive sleep apnea syndrome patients Source: Annual Congress 2010 - Clinical aspects of sleep apnoea Year: 2010
Role of CPAP treatment in elderly with moderate obstructive sleep apnea Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects Year: 2019
Effects of CPAP treatment on physical fitness in patients with obstructive sleep apnoea syndrome (OSAS) Source: Eur Respir J 2003; 22: Suppl. 45, 97s Year: 2003
Long term effects of CPAP therapy in sleep apnea patients with metabolic syndrome Source: Annual Congress 2010 - Nocturnal cardiology: chronic heart failure, acute chest syndrome, coronary artery disease and collagen vascular disease Year: 2010
PAI-uPA system in patients with obstructive sleep apnea syndrome (OSAS) in CPAP treatment Source: Annual Congress 2012 - Cardiovascular disease and sleep-disordered breathing Year: 2012
Oral devices in the treatment of obstructive sleep apnoea short and long-term treatment Source: Eur Respir J 2003; 22: Suppl. 45, 95s Year: 2003
Respiratory failure in obstructive sleep apnea syndrome (OSAS)- is CPAP therapy alone adequate? Source: Eur Respir J 2005; 26: Suppl. 49, 111s Year: 2005
Effect of five-years treatment with nCPAP on left ventricle function in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2001; 18: Suppl. 33, 418s Year: 2001
Predictors of long-term PAP-adherence in obstructive sleep apnea syndrome Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health Year: 2012
Compliance with nCPAP in elderly patients with obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2004; 24: Suppl. 48, 569s Year: 2004
Long-term CPAP compliance in women with obstructive sleep apnoea Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health Year: 2012
The use of systemic corticosteroids in children with obstructive sleep apnea syndrome Source: International Congress 2019 – Evaluation of breathing in children when they are asleep, healthy or ill Year: 2019